Prof Yasuhito Nannya, MD, PhD is an expert in Hematology at Clinical Research Tokyo Hospital (Japan). As of November 2026, ScienceLeadR ranks Yasuhito Nannya in the top 1% of experts in Japan for Leukemia. Yasuhito Nannya has authored 532 publications, the most recent in 2026, and is an investigator in 1 clinical trial, 1 of them ongoing. SLR score: 1,385 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Yasuhito Nannya, MD, PhD Clinical Research Tokyo Hospital Japan
1 385 ScienceLeadR Reputation 1385
Network Map

Hematology

Subspecialties: Oncology - Genetics - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2004 - 2026
Source: PubMed

University of Tokyo - Professor

2004 - 2026

Kyoto University - Program oriented professor

2016 - 2026

Tokyo Metropolitan Institute of Medical Science

2021 - 2026

Clinical Research Tokyo Hospital

2021 - 2026

California Institute Of Medical Science

2022 - 2026

Nihon Institute of Medical Science

2023 - 2026

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 532

Citations

Citations: 10 369 1st author: 20 Last author: 27 Unique author: 10


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Clinical spectrum and hematopoietic stem cell transplantation outcomes in Japanese patients with GATA2 deficiency.
PMID 43013244 — cells, blood, microscopy, electron, scanning transmission, hematopoietic stem cell transplantation, gata2 deficiency, stem cells, cell transplantation, stem cell transplantation, hematopoietic stem cells, hematologic diseases, transplantation
Int J Hematol20260
Nodal T Follicular Helper Cell Lymphoma With Epstein-Barr Virus-Positive Neoplastic T Cells Derived From Clonal Hematopoiesis.
PMID 42959303 — cells, hematopoiesis, bone marrow, lymphoma, clonal hematopoiesis, herpesvirus 4, human, viruses, mutation, t-lymphocytes, helper-inducer
EJHaem20260
Inflammasome activation promotes the progression of myelodysplastic syndrome.
PMID 42946195 — myelodysplastic syndromes, bone marrow, hematology, phenotype, inflammasomes, leukemia, leukemia, myeloid, acute, caspases, leukemia, myeloid, research
Exp Hematol20260
Passive acquisition of hepatitis B virus antibodies after allogeneic hematopoietic cell transplantation.
PMID 42902498 — hepatitis b surface antigens, cells, research design, blood, hepatitis b virus, hepatitis b antibodies, antibodies, immunoglobulins, herpesvirus 1, cercopithecine, viruses, cell transplantation, blood platelets, hepatitis b, transplantation, infections, hepatitis
Transfusion20260
Flow cytometric assessment of T-cell receptor β-chain constant region 1/2 skewing as a surrogate marker for clonality in human T-cell leukaemia virus type-1-infected cells.
PMID 42885517 — cells, flow cytometry, hematology, viruses, t-lymphocytes, receptors, antigen, t-cell
Br J Haematol20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Recruiting 1

By type:

Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow Failure Syndromes
NCT05436587 — bone marrow failure disorders, research design, bone marrow, pancytopenia, chromosome fragility, phenotype, congenital bone marrow failure syndromes, biopsy, exome, exome sequencing, mutation, universities
N/ARecruiting2022

LeadR Networks

Main global connection map